These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24533977)
21. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. Jeon SG; Kayama H; Ueda Y; Takahashi T; Asahara T; Tsuji H; Tsuji NM; Kiyono H; Ma JS; Kusu T; Okumura R; Hara H; Yoshida H; Yamamoto M; Nomoto K; Takeda K PLoS Pathog; 2012; 8(5):e1002714. PubMed ID: 22693446 [TBL] [Abstract][Full Text] [Related]
22. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Philippe D; Heupel E; Blum-Sperisen S; Riedel CU Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218 [TBL] [Abstract][Full Text] [Related]
23. Li Y; Li Q; Yuan R; Wang Y; Guo C; Wang L Theranostics; 2024; 14(7):2719-2735. PubMed ID: 38773969 [No Abstract] [Full Text] [Related]
24. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease. Lu F; Fernandes SM; Davis AE Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925 [TBL] [Abstract][Full Text] [Related]
25. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526 [TBL] [Abstract][Full Text] [Related]
26. Bifidobacterium breve CBT BR3 is effective at relieving intestinal inflammation by augmenting goblet cell regeneration. Park IS; Kim JH; Yu J; Shin Y; Kim K; Kim TI; Kim SW; Cheon JH J Gastroenterol Hepatol; 2023 Aug; 38(8):1346-1354. PubMed ID: 37157108 [TBL] [Abstract][Full Text] [Related]
27. Effects of the probiotic formulation VSL#3 on colitis in weanling rats. Fitzpatrick LR; Hertzog KL; Quatse AL; Koltun WA; Small JS; Vrana K J Pediatr Gastroenterol Nutr; 2007 May; 44(5):561-70. PubMed ID: 17460487 [TBL] [Abstract][Full Text] [Related]
28. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii. Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208 [TBL] [Abstract][Full Text] [Related]
29. Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis. Zheng B; van Bergenhenegouwen J; van de Kant HJ; Folkerts G; Garssen J; Vos AP; Morgan ME; Kraneveld AD Benef Microbes; 2016; 7(2):205-13. PubMed ID: 26645352 [TBL] [Abstract][Full Text] [Related]
30. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters. Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096 [TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of live and dead Salmonella-based vector strain on the course of colitis in mice. Wagnerova A; Babickova J; Liptak R; Celec P; Gardlik R Lett Appl Microbiol; 2016 Nov; 63(5):340-346. PubMed ID: 27501439 [TBL] [Abstract][Full Text] [Related]
36. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687 [TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150 [TBL] [Abstract][Full Text] [Related]
38. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model]. Wan YM; Zhu YQ; Xia B; Luo J Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418 [TBL] [Abstract][Full Text] [Related]
39. Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats. Izumi H; Minegishi M; Sato Y; Shimizu T; Sekine K; Takase M Pediatr Res; 2015 Oct; 78(4):407-16. PubMed ID: 26083761 [TBL] [Abstract][Full Text] [Related]